JO
BHVN

John Overdeck’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

John Overdeck’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,400
Closed -$2.97M – 3032
2022
Q2 		$2.97M Sell
20,400
-136,963
-87% -$17.5M 0.01% 990
2022
Q1 		$18.7M Sell
157,363
-42,430
-21% -$5.29M 0.06% 406
2021
Q4 		$27.5M Buy
199,793
+33,771
+20% +$4.29M 0.06% 372
2021
Q3 		$23.1M Buy
166,022
+120,165
+262% +$15M 0.05% 420
2021
Q2 		$4.45M Sell
45,857
-90,748
-66% -$7.37M 0.01% 1273
2021
Q1 		$9.34M Sell
136,605
-59,270
-30% -$4.79M 0.02% 729
2020
Q4 		$16.8M Sell
195,875
-79,990
-29% -$6.78M 0.05% 423
2020
Q3 		$17.9M Buy
275,865
+189,121
+218% +$12.4M 0.06% 326
2020
Q2 		$6.34M Buy
86,744
+1,781
+2% +$94.8K 0.03% 550
2020
Q1 		$2.89M Sell
84,963
-164,516
-66% -$7.52M 0.02% 774
2019
Q4 		$13.6M Buy
249,479
+189,419
+315% +$9.38M 0.04% 500
2019
Q3 		$2.51M Buy
60,060
+44,360
+283% +$1.87M 0.01% 1255
2019
Q2 		$688K Sell
15,700
-211,966
-93% -$11.9M ﹤0.01% 2247
2019
Q1 		$11.7M Buy
+227,666
New +$9.84M 0.04% 595
2017
Q3 		– Sell
-13,618
Closed -$340K – 3507
2017
Q2 		$340K Buy
+13,618
New +$314K ﹤0.01% 2574

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

John Overdeck's BHVN Position: Q3 2022 in Review

John Overdeck sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 20,400 shares — an estimated $2.97M sold.

John Overdeck first reported a position in BHVN in Q2 2017 and held it in 15 quarters. The position peaked at $27.5M in Q4 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • John Overdeck reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • John Overdeck sold 20,400 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $2.97M.
  • John Overdeck first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 15 quarters.
  • John Overdeck's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $27.5M in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.